These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 27662091)

  • 1. Editing DNA Methylation in the Mammalian Genome.
    Liu XS; Wu H; Ji X; Stelzer Y; Wu X; Czauderna S; Shu J; Dadon D; Young RA; Jaenisch R
    Cell; 2016 Sep; 167(1):233-247.e17. PubMed ID: 27662091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase.
    Yamazaki T; Hatano Y; Handa T; Kato S; Hoida K; Yamamura R; Fukuyama T; Uematsu T; Kobayashi N; Kimura H; Yamagata K
    PLoS One; 2017; 12(5):e0177764. PubMed ID: 28542388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
    Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
    Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase.
    Stepper P; Kungulovski G; Jurkowska RZ; Chandra T; Krueger F; Reinhardt R; Reik W; Jeltsch A; Jurkowski TP
    Nucleic Acids Res; 2017 Feb; 45(4):1703-1713. PubMed ID: 27899645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
    Dong E; Ruzicka WB; Grayson DR; Guidotti A
    Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenome editing strategies for the functional annotation of CTCF insulators.
    Tarjan DR; Flavahan WA; Bernstein BE
    Nat Commun; 2019 Sep; 10(1):4258. PubMed ID: 31534142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells.
    Gu T; Lin X; Cullen SM; Luo M; Jeong M; Estecio M; Shen J; Hardikar S; Sun D; Su J; Rux D; Guzman A; Lee M; Qi LS; Chen JJ; Kyba M; Huang Y; Chen T; Li W; Goodell MA
    Genome Biol; 2018 Jul; 19(1):88. PubMed ID: 30001199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
    Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
    Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmable targeted epigenetic editing using CRISPR system in Bombyx mori.
    Liu Y; Ma S; Chang J; Zhang T; Chen X; Liang Y; Xia Q
    Insect Biochem Mol Biol; 2019 Jul; 110():105-111. PubMed ID: 31022512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
    Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
    Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dCas9: A Versatile Tool for Epigenome Editing.
    Brocken DJW; Tark-Dame M; Dame RT
    Curr Issues Mol Biol; 2018; 26():15-32. PubMed ID: 28879853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR-Cas9-Based Near-Infrared Upconversion-Activated DNA Methylation Editing System.
    Chi J; Zhao J; Wei S; Li Y; Zhi J; Wang H; Hou X; Hu L; Zheng X; Gao M
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6043-6052. PubMed ID: 33525876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
    Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
    Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.
    Hanzawa N; Hashimoto K; Yuan X; Kawahori K; Tsujimoto K; Hamaguchi M; Tanaka T; Nagaoka Y; Nishina H; Morita S; Hatada I; Yamada T; Ogawa Y
    Sci Rep; 2020 Mar; 10(1):5181. PubMed ID: 32198422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing Mechanoinductive DSP Expression by CRISPR/dCas9-mediated Epigenome Editing.
    Qu J; Zhu L; Zhou Z; Chen P; Liu S; Locy ML; Thannickal VJ; Zhou Y
    Am J Respir Crit Care Med; 2018 Sep; 198(5):599-609. PubMed ID: 29924937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tet1-dependent epigenetic modification of BDNF expression in dorsal horn neurons mediates neuropathic pain in rats.
    Hsieh MC; Lai CY; Ho YC; Wang HH; Cheng JK; Chau YP; Peng HY
    Sci Rep; 2016 Nov; 6():37411. PubMed ID: 27857218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.